Drug intelligence / Profile preview

dayzero umbilical cord stem cells

Development stage: Unknown
Lead developer: ZEO ScientifiX
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intraarticular, Topical, Intralesional

Overview

DayZero Umbilical Cord Stem Cells is a perinatal cell therapy product developed and manufactured by ZEO ScientifiX. Composed of stem cells harvested from the umbilical cord, the product is designed to leverage the regenerative and immunomodulatory properties of young, potent cells to treat conditions in orthopedics, pain management, and wound care. Unlike adult-derived stem cells, umbilical cord-derived cells are characterized by higher proliferative capacity and lower immunogenicity. The product is commercially available in specific jurisdictions, such as Florida and Utah, under state-level legislation (e.g., Florida SB 1768) that enables the use of regenerative medicine products. It is typically administered via injection or topical application to facilitate tissue repair and reduce inflammation.

Brand names: DayZero Umbilical Cord Stem Cells
Other names: DayZeroumbilical cord-derived stem cells

Beyond the preview

Go deeper on dayzero umbilical cord stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on dayzero umbilical cord stem cells.

Explore the full profile